Dasatinib (UK) — Patient-Friendly Guide

Dasatinib is a prescription medicine used to treat certain types of leukaemia. It belongs to a group of medicines called protein kinase inhibitors (targeted cancer therapies). This page explains what dasatinib is, how it works, how it is used, and important safety and practical points for people in the United Kingdom.

Always follow the instructions given by your healthcare team. If you are unsure about your schedule, missed doses, or side effects, contact your clinic or pharmacist for personalised advice.

Basic product information

How dasatinib works (mechanism of action)

Dasatinib blocks abnormal signalling inside cells. It targets enzymes called kinases, including: BCR-ABL (often found in certain forms of leukaemia) and other related kinases.

• Stops abnormal cell growth: By inhibiting BCR-ABL and related pathways, dasatinib reduces the signals that drive uncontrolled leukaemia cell survival and multiplication.
• Can help restore normal blood counts: In many patients, this targeted action can reduce leukaemia burden over time.
• Targets multiple kinases: Dasatinib has a broader kinase profile than some older treatments, contributing to its usefulness in certain clinical settings.

Typical use in the UK

Dasatinib is used to treat specific subtypes of leukaemia, most commonly those involving the BCR-ABL1 fusion gene. Your exact treatment plan depends on test results, disease stage, and previous therapies.

Common indications

• Chronic Myeloid Leukaemia (CML): Including chronic phase, accelerated phase, or blast crisis in appropriate patients.
• Ph+ Acute Lymphoblastic Leukaemia (Ph+ ALL): In certain adults and paediatric patients depending on clinical criteria.

Indications may vary by age group, disease phase, and whether treatment is first-line or after other medicines. Your specialist will confirm suitability based on your individual situation and the latest prescribing information.

Pharmacokinetics (how the body handles dasatinib)

Pharmacokinetics describe how a medicine is absorbed, distributed, metabolised, and eliminated. For dasatinib:

• Absorption: Dasatinib is absorbed after oral dosing. Food may affect the rate and extent of absorption for some people.
• Distribution: It can distribute into tissues, and it may bind to plasma proteins.
• Metabolism: Dasatinib is mainly metabolised in the liver (commonly via CYP enzymes). This is why certain medicines (especially “enzyme inducers” or strong inhibitors) can be important to avoid.
• Elimination: Metabolites are cleared primarily through faeces, with smaller amounts eliminated via urine.
• Half-life: The elimination half-life is variable and can support once-daily dosing for many regimens (your clinic will specify your schedule).

Your healthcare team may monitor blood counts and liver function, and sometimes watch for drug interactions based on your medication list.

Dosing and timing

Do not change your dose unless your specialist advises it. Doses can vary depending on the diagnosis, disease stage, blood tests, side effects, and response.

How it is usually taken

• Frequency: Often once daily, but follow your specific instructions.
• Time of day: Many people take it at the same time each day to help maintain consistency.
• With or without food: Follow guidance from your prescriber and the product leaflet. Food can affect absorption.

Missed dose (general guidance)

• If you miss a dose, do not double up.
• Take the next dose at the usual time and inform your clinic/pharmacist if you are unsure.
• Because treatment schedules are important for safety and effectiveness, seek guidance for repeated missed doses.

Food interactions (what to consider)

Food may influence how much dasatinib your body absorbs and how quickly it reaches peak levels. In practice, this means your healthcare team may recommend a consistent approach with meals.

• Consistency matters: If your clinician advises taking dasatinib with a particular meal pattern, stick to it.
• Grapefruit and Seville oranges: These can interact with many medicines through effects on liver enzymes. Your pharmacist can advise whether to avoid them with dasatinib.

If you have been told to take dasatinib on an empty stomach or with food, follow that exact instruction and ask for clarification if your usual routine differs.

Alcohol interactions

Alcohol is not always listed as a direct interaction with every targeted cancer medicine, but it can still be relevant. Dasatinib is processed in the liver and can cause liver-related side effects in some patients.

• Limit alcohol: To reduce strain on the liver and lower the risk of side effects such as fatigue or nausea.
• Watch liver symptoms: Contact your clinic promptly if you develop yellowing of the skin/eyes, dark urine, severe tiredness, or upper right abdominal pain.

If you are unsure what level of alcohol (if any) is appropriate for you, ask your specialist or pharmacist.

Medicine interactions (important safety topic)

Dasatinib can interact with other medicines, especially those affecting liver enzymes and transport systems. Always keep a current list of all medicines and supplements you take—including non-prescription products.

Medicines commonly of concern

• Strong enzyme inducers (may reduce dasatinib levels): These can include certain medicines used for seizures (anti-epileptics) or some treatments for infections. Examples vary—ask your pharmacist.
• Strong inhibitors (may increase dasatinib levels): Some antifungals and certain antibiotics can raise risk of side effects.
• Acid-reducing medicines: Drugs that change stomach acidity may affect absorption for some kinase inhibitors. Your pharmacist can advise on spacing and options.
• Herbal products: St John’s Wort (Hypericum perforatum) is a frequent cause of interactions and is generally avoided with many cancer medicines.

Always check before starting

• New prescription medicines
• Over-the-counter pain relief, cold/flu products, and antacids
• Herbal supplements and vitamins (especially high-dose supplements)

Your healthcare team may use interaction-checking tools and may recommend alternative medicines to reduce risks.

Safety profile: what to watch for

Like all medicines, dasatinib can cause side effects. Some are common and manageable, while others require prompt medical attention. Your clinic will monitor you with blood tests and symptom checks.

Common side effects

• Low blood counts (myelosuppression): which can lead to anaemia, infections, or bleeding/bruising.
• Nausea, diarrhoea or constipation
• Fatigue
• Headache
• Rash and skin dryness
• Fluid-related effects: swelling in some cases (e.g., ankles) and sometimes weight gain

Serious side effects—seek urgent help

Contact your urgent care service or seek immediate medical advice if you experience:

• Shortness of breath, chest pain, sudden weight gain, or swelling that is worsening (could indicate fluid retention or breathing-related complications).
• Unusual bleeding (e.g., nosebleeds that won’t stop, blood in urine or stool, coughing blood) or severe bruising.
• Signs of infection: fever, chills, severe sore throat, or feeling acutely unwell.
• Severe or persistent vomiting, dehydration, or severe diarrhoea.
• Severe allergic-type reactions: facial swelling, difficulty breathing, widespread rash with blistering.
• Severe liver symptoms: yellow skin/eyes, dark urine, severe abdominal pain, marked fatigue.

Monitoring during treatment

• Blood tests: full blood count regularly to check white cells, platelets, and haemoglobin.
• Liver function tests: to detect liver enzyme changes.
• Heart and breathing assessment: if you report symptoms such as breathlessness or swelling.
• Disease response monitoring: tests for leukaemia response as scheduled by your specialist.

Practical use tips

• Use consistent timing: Taking your dose at the same time each day helps reduce missed doses and supports adherence.
• Keep a medication list: Include prescription medicines, OTC items, supplements, and herbal products.
• Stay hydrated and manage symptoms early: If you develop nausea or diarrhoea, contact your clinic early— prompt supportive care can make treatment easier.
• Protect your skin: Use gentle skincare if you develop rash or irritation. Avoid harsh products unless advised.
• Bleeding precautions: Use caution with activities that may cause bruising; talk to your team before dental procedures if platelets are low.
• Avoid grapefruit if advised: Ask your pharmacist whether certain citrus products should be avoided for your regimen.
• Infection prevention: If your blood counts are low, follow infection prevention advice from your clinic, such as promptly treating fevers and avoiding close contact with sick individuals when possible.

Handling and tablet safety

Cytotoxic medicines can be harmful if handled incorrectly. If you need to handle tablets (for example, if others are helping you), follow the instructions in your product packaging regarding safe handling and disposal.

Alternative options (what may be considered)

If dasatinib is not suitable due to side effects, interaction concerns, or response, specialist clinicians may consider other targeted options for Ph+ leukaemias or CML depending on your specific circumstances.

Possible alternatives

• Other BCR-ABL inhibitors: Several kinase inhibitors exist and differ in side-effect profiles and interaction potential.
• Changing dose: Sometimes side effects lead to dose adjustment before switching medicines.
• Supportive care changes: Medicines to manage symptoms (e.g., anti-nausea therapy, infection support) may be added.
• Other treatment strategies: For some patients, additional or alternative therapies may be considered by the oncology team.

The best alternative depends on your diagnosis (CML phase or Ph+ ALL), previous treatments, genetic markers, and your overall health. Always discuss options with your specialist.

Market & legal context in the United Kingdom

In the UK, cancer medicines are regulated and marketed under the Medicines and Healthcare products Regulatory Agency (MHRA) framework. Availability can vary due to supply logistics, manufacturing updates, and prescribing criteria.

Dasatinib is typically used within specialist haematology/oncology services where treatment decisions are guided by national standards and specialist guidance. During treatment, patients usually have scheduled monitoring and review.

Recent guidance considerations (general)

• Safety monitoring emphasis: Ongoing pharmacovigilance encourages prompt reporting of breathlessness, fluid retention symptoms, and signs of infection or bleeding.
• Interaction awareness: Updated interaction advice and medication reconciliation remain important due to common use of acid-reducing medicines, antibiotics, and antifungals in real life.
• Consistent administration: Clinicians frequently emphasise taking medicines at the same time each day and following guidance about meals/acid reducers.

Your clinic may also follow disease-specific guidance issued by professional bodies and health authorities. Always refer to the most current advice provided to you by your treating team.

Delivery and availability in the UK

Availability can depend on:

• Stock levels with suppliers and wholesalers
• Tablet strength and packaging requirements
• Seasonal or logistics-related demand
• Manufacturer supply schedules

A reputable UK pharmacy will usually provide clear information about:

• Expected delivery times
• Delivery options (standard or express, where available)
• Order cut-off times for dispatch
• Cold/temperature requirements (most tablets do not require special refrigeration, but always follow the packaging instructions)

If your required strength or pack size is temporarily out of stock, the pharmacy may discuss alternatives such as different pack sizes or arrangements to avoid treatment interruption. Keep in mind that continuity of dosing is important in leukaemia therapy.

FAQ about dasatinib

1. What is dasatinib used for?

Dasatinib is used for certain types of leukaemia, most often where genetic tests show the BCR-ABL1 (Ph+) mechanism involved. Your specialist decides if it’s appropriate for your diagnosis and treatment history.

2. How should I take dasatinib?

Take it exactly as instructed by your healthcare team. Most regimens are taken once daily at around the same time each day. Food can affect absorption, so follow the advice given to you for meals or fasting.

3. Can I take it with food?

Dasatinib may be affected by food intake. Your prescriber or pharmacist will advise whether to take it with food or on an empty stomach. The key is to remain consistent with your plan.

4. What should I do if I miss a dose?

Do not double up. Take your next dose at the usual time and contact your pharmacist or clinic for advice if you are unsure, especially if multiple doses are missed.

5. Are there foods or drinks I should avoid?

Grapefruit products may be avoided with many medicines that use similar metabolic pathways; ask your pharmacist whether this applies to your regimen. Also, try to keep meal patterns consistent.

6. Is alcohol safe during treatment?

Alcohol may increase fatigue and can affect the liver. Because dasatinib may also impact liver function, it’s best to limit alcohol and discuss a safe amount with your healthcare team.

7. What interactions are most important?

Interaction risk is highest with medicines that affect liver enzymes or stomach acidity (and some herbal products like St John’s Wort). Always check with your pharmacist before starting new medicines, including OTC products.

8. What side effects are common?

Common effects include low blood counts, nausea, fatigue, diarrhoea/constipation, rash, and sometimes fluid-related swelling. Many side effects can be managed, but report them promptly.

9. When should I seek urgent medical help?

Seek urgent help for breathing difficulties, chest pain, severe swelling or sudden weight gain, bleeding, signs of infection (fever), severe diarrhoea/vomiting with dehydration, or severe allergic-type reactions.

10. Will my dose change over time?

It can. Dose adjustments may occur based on blood counts, side effects, and how your disease responds to treatment. Only adjust dosing if your clinician instructs you.

11. Are there alternative treatments if dasatinib isn’t right for me?

Yes. Other targeted kinase inhibitors or supportive measures may be considered depending on your diagnosis and response. Discuss alternatives with your specialist team.

Summary

Dasatinib is a targeted medicine that works by blocking abnormal signalling pathways involved in certain leukaemias. It is taken as a tablet, usually once daily, with careful attention to timing, food guidance, and potential interactions. Because dasatinib can affect blood counts and sometimes the lungs or liver, regular monitoring and prompt reporting of symptoms are important.

If you have questions about your specific regimen, side effects, or interactions, speak to your healthcare team or pharmacist for guidance tailored to you.